Clinical Trial Update: Neoadjuvant Chemotherapy Using Doxorubicin and Paclitaxel in Treating Women With Large Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated neoadjuvant chemotherapy with doxorubicin and paclitaxel in women with large breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Doxorubicin (doxorubicin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED